Atea pharmaceuticals to present and provide a business update at the 7th annual evercore healthconx conference

Boston, nov. 26, 2024 (globe newswire) -- atea pharmaceuticals, inc. (nasdaq: avir) (“atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that jean-pierre sommadossi, phd, chief executive officer and founder of atea pharmaceuticals, together with other members of the atea management team, will participate in a fireside chat and present a business update at the 7th annual evercore healthconx conference on wednesday, december 4, 2024 at 9:35 a.m. et.
EVR Ratings Summary
EVR Quant Ranking